Mediclinic shares surge 17% in London as Abu Dhabi drops co-payment rule
A change in Abu Dhabi’s medical aid regulations led dual-listed Mediclinic International’s share price to jump 17% to 855.61p in London on Thursday. Its share price is likely to surge on the JSE when it reopens on Friday, after Thursday’s Freedom Day holiday. Mediclinic issued a statement via the JSE’s Sens service on Friday morning saying a 20% co-payment for holders of Thiqa medical insurance cards had been waived by Abu Dhabi’s crown prince, Sheikh Mohamed bin Zayed al-Nahyan. Abu Dhabi introduced the 20% co-payment system in July 2016, five months after Mediclinic acquired Al Noor Hospital Group for about £1.5bn. In its interim results statement released in November, Mediclinic said it expected the co-payment system to cost it about 150-million United Arab Emirates Dirham (about R545m) in the financial year under way. The Financial Times reported on Thursday that investors had written off Mediclinic’s investment in Al Noor, quoting JPMorgan Cazenove: "In our view, Mediclinic pro...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.